LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.95 | 84.90 | 3529 | 4952 | 0.7126 | 0.8877 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.95 | 84.90 | 3162 | 4952 | 0.6385 | 0.8527 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.95 | 84.90 | 3173 | 4952 | 0.6407 | 0.8538 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 48.65 | 84.90 | 338 | 5328 | 0.0634 | 0.2603 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 48.65 | 84.90 | 3677 | 5328 | 0.6900 | 0.8795 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 48.65 | 84.90 | 3296 | 5328 | 0.6185 | 0.8454 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 48.65 | 84.90 | 3305 | 5328 | 0.6202 | 0.8463 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 50.36 | 84.90 | 418 | 5651 | 0.0740 | 0.3011 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 50.36 | 84.90 | 3894 | 5651 | 0.6891 | 0.8807 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 50.36 | 84.90 | 3447 | 5651 | 0.6100 | 0.8432 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 50.36 | 84.90 | 3459 | 5651 | 0.6121 | 0.8443 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 52.06 | 84.90 | 489 | 5990 | 0.0816 | 0.3299 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 52.06 | 84.90 | 4112 | 5990 | 0.6864 | 0.8811 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 52.06 | 84.90 | 3602 | 5990 | 0.6013 | 0.8410 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 52.06 | 84.90 | 3609 | 5990 | 0.6024 | 0.8416 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 84.90 | 511 | 6252 | 0.0817 | 0.3356 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 84.90 | 4270 | 6252 | 0.6829 | 0.8807 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 84.90 | 3697 | 6252 | 0.5913 | 0.8375 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 84.90 | 3712 | 6252 | 0.5937 | 0.8387 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 84.90 | 573 | 6567 | 0.0872 | 0.3558 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 84.90 | 4491 | 6567 | 0.6838 | 0.8824 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 84.90 | 3927 | 6567 | 0.5979 | 0.8426 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.48 | 84.90 | 3944 | 6567 | 0.6005 | 0.8439 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.18 | 84.90 | 630 | 6963 | 0.0905 | 0.3706 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.18 | 84.90 | 4680 | 6963 | 0.6721 | 0.8788 | MN20160318_Q02 | K14 |